Bridgeway Capital Management, LLC Kezar Life Sciences, Inc. Transaction History

Bridgeway Capital Management, LLC

$4.44 Billion
Q3 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 11,600 shares of KZR stock, worth $86,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,600

Previous 108,600 89.32%

Holding current value

$86,536

Previous $65,000 87.69%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $0.77 $51,410 - $74,690	-97,000 Reduced 89.32%	11,600 $8,000
Q1 2024 May 15, 2024	SELL	$0.8 - $1.05 $40,000 - $52,500	-50,000 Reduced 31.53%	108,600 $97,000
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.15 $109,080 - $174,225	-151,500 Reduced 48.86%	158,600 $150,000
Q3 2023 Nov 14, 2023	BUY	$1.08 - $2.54 $123,768 - $291,084	114,600 Added 58.62%	310,100 $369,000
Q2 2023 Aug 14, 2023	BUY	$2.31 - $3.06 $451,605 - $598,230	195,500 New	195,500 $478,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $1.42 Million - $2.12 Million	-115,400 Reduced 80.93%	27,200 $452,000
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $428,544 - $963,071	-57,600 Reduced 28.77%	142,600 $2.38 Million
Q3 2021 Nov 15, 2021	SELL	$4.85 - $9.73 $121,249 - $243,250	-25,000 Reduced 11.1%	200,200 $1.73 Million
Q2 2021 Aug 16, 2021	SELL	$4.93 - $6.46 $49,300 - $64,600	-10,000 Reduced 4.25%	225,200 $1.22 Million
Q1 2021 May 17, 2021	BUY	$5.24 - $6.99 $1.23 Million - $1.64 Million	235,200 New	235,200 $1.4 Million
Q2 2020 Aug 14, 2020	SELL	$3.6 - $7.75 $179,895 - $387,275	-49,971 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.77 - $5.75 $78,108 - $162,138	-28,198 Reduced 36.07%	49,971 $218,000
Q4 2019 Feb 14, 2020	BUY	$2.5 - $4.26 $90,927 - $154,940	36,371 Added 87.02%	78,169 $313,000
Q3 2019 Nov 14, 2019	BUY	$3.0 - $7.58 $125,394 - $316,828	41,798 New	41,798 $137,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $510M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Kezar Life Sciences, Inc. Transaction History